Back to Search
Start Over
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
- Source :
- Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-6 (2022)
- Publication Year :
- 2022
- Publisher :
- BMC, 2022.
-
Abstract
- An amendment to this paper has been published and can be accessed via the original article.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 17569966
- Volume :
- 41
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Experimental & Clinical Cancer Research
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7ea489c1d2f64a7ea2dea114313c315d
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13046-022-02247-y